United States · FDA National Drug Code directory
Neo-Synephrine Severe
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0225-0811_54edb0ef-b9fc-8470-e063-6394a90a5885
- Product NDC
- 0225-0811
- Form
- SPRAY
- Composition / generic term
- PHENYLEPHRINE HYDROCHLORIDE
- Labeler
- BF ASCHER AND CO INC
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20260601
- Source listing expiry
- 20271231
Source-listed ingredients
- PHENYLEPHRINE HYDROCHLORIDE — 1 g/100mL
These values do not establish equivalence or a dose recommendation.
Packages
- 15 mL in 1 BOTTLE, SPRAY (0225-0811-47) · 0225-0811-47
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →